Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MONTELUKAST Cause Product prescribing issue? 46 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Product prescribing issue have been filed in association with MONTELUKAST (Montelukast). This represents 0.2% of all adverse event reports for MONTELUKAST.

46
Reports of Product prescribing issue with MONTELUKAST
0.2%
of all MONTELUKAST reports
0
Deaths
20
Hospitalizations

How Dangerous Is Product prescribing issue From MONTELUKAST?

Of the 46 reports, 20 (43.5%) required hospitalization.

Is Product prescribing issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MONTELUKAST. However, 46 reports have been filed with the FAERS database.

What Other Side Effects Does MONTELUKAST Cause?

Asthma (8,372) Dyspnoea (6,354) Wheezing (5,159) Drug ineffective (3,539) Cough (3,475) Therapeutic product effect incomplete (3,352) Anxiety (2,994) Loss of personal independence in daily activities (2,736) Sleep disorder due to a general medical condition (2,101) Obstructive airways disorder (2,073)

What Other Drugs Cause Product prescribing issue?

DUPILUMAB (1,715) POLYETHYLENE GLYCOL 3350 (1,439) LENALIDOMIDE (948) OXYCODONE (646) RIVAROXABAN (359) ACETAMINOPHEN\OXYCODONE (347) ETONOGESTREL (311) ACETAMINOPHEN\HYDROCODONE (298) CERTOLIZUMAB PEGOL (297) CABOZANTINIB S-MALATE (294)

Which MONTELUKAST Alternatives Have Lower Product prescribing issue Risk?

MONTELUKAST vs MONTELUKAST\MONTELUKAST MONTELUKAST vs MONTMORILLONITE MONTELUKAST vs MORNIFLUMATE MONTELUKAST vs MOROCTOCOG ALFA MONTELUKAST vs MORPHINE

Related Pages

MONTELUKAST Full Profile All Product prescribing issue Reports All Drugs Causing Product prescribing issue MONTELUKAST Demographics